Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hassan Yousefnia

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 23, 2015
Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMPHassan Yousefnia, Samaneh Zolghadri
Annals of Nuclear Medicine|October 11, 2025
Evaluation of cumulative absorbed dose in tumors of various sizes regarding <sup>227</sup>Th-based targeted alpha therapy: an in-depth analysisSepideh Shafiei, Hassan Yousefnia
Current Radiopharmaceuticals|December 12, 2022
An Overview of Radiolabeled RGD Peptides for Theranostic ApplicationsFateme Badipa, Behrouz Alirezapour, Hassan Yousefnia
EJNMMI Physics|October 27, 2025
Quantifying DNA strand breaks from targeted alpha emitters <sup>225</sup>Ac and <sup>227</sup>Th via Geant4-DNA: implications for RBE and cell survivalSamaneh Zolghadri, Payman Rafiepour, Hassan Yousefnia
Current Radiopharmaceuticals|November 8, 2023
Astatine-211 Radiopharmaceuticals; Status, Trends, and the FutureMobina Rabiei, Mahboobeh Asadi, Hassan Yousefnia
Journal of Medical Physics|October 10, 2022
Human Absorbed Dose Estimation of <sup>111</sup>In-DOTA-PR81 as a Novel High Potential Agent for Breast Cancer ImagingHassan Yousefnia, Samaneh Zolghadri, Behrouz Alirezapour
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 12, 2015
Estimated human absorbed dose of ¹⁷⁷Lu-BPAMD based on mice data: Comparison with ¹⁷⁷Lu-EDTMPHassan Yousefnia, Samaneh Zolghadri, Saeed Shanehsazzadeh
Journal of Medical Physics|July 15, 2015
Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in ratsHassan Yousefnia, Samaneh Zolghadri, Amir Reza Jalilian
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 30, 2024
Preclinical studies and absorbed dose estimation of [<sup>89</sup>Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumorsSamaneh Zolghadri, Fatemeh Mohammadpour-Ghazi, Hassan Yousefnia
World Journal of Nuclear Medicine|September 6, 2014
Preparation and evaluation of Lu-(177) phytate Complex for RadiosynovectomyHassan Yousefnia, Amir Reza Jalilian, Samaneh Zolghadri
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 23, 2015
Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMPHassan Yousefnia, Samaneh Zolghadri
Annals of Nuclear Medicine|October 11, 2025
Evaluation of cumulative absorbed dose in tumors of various sizes regarding <sup>227</sup>Th-based targeted alpha therapy: an in-depth analysisSepideh Shafiei, Hassan Yousefnia
Current Radiopharmaceuticals|December 12, 2022
An Overview of Radiolabeled RGD Peptides for Theranostic ApplicationsFateme Badipa, Behrouz Alirezapour, Hassan Yousefnia
EJNMMI Physics|October 27, 2025
Quantifying DNA strand breaks from targeted alpha emitters <sup>225</sup>Ac and <sup>227</sup>Th via Geant4-DNA: implications for RBE and cell survivalSamaneh Zolghadri, Payman Rafiepour, Hassan Yousefnia
Current Radiopharmaceuticals|November 8, 2023
Astatine-211 Radiopharmaceuticals; Status, Trends, and the FutureMobina Rabiei, Mahboobeh Asadi, Hassan Yousefnia
Journal of Medical Physics|October 10, 2022
Human Absorbed Dose Estimation of <sup>111</sup>In-DOTA-PR81 as a Novel High Potential Agent for Breast Cancer ImagingHassan Yousefnia, Samaneh Zolghadri, Behrouz Alirezapour
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 12, 2015
Estimated human absorbed dose of ¹⁷⁷Lu-BPAMD based on mice data: Comparison with ¹⁷⁷Lu-EDTMPHassan Yousefnia, Samaneh Zolghadri, Saeed Shanehsazzadeh
Journal of Medical Physics|July 15, 2015
Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in ratsHassan Yousefnia, Samaneh Zolghadri, Amir Reza Jalilian
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 30, 2024
Preclinical studies and absorbed dose estimation of [<sup>89</sup>Zr]Zr-DFO-Bevacizumab for PET imaging of VEGF-expressing tumorsSamaneh Zolghadri, Fatemeh Mohammadpour-Ghazi, Hassan Yousefnia
World Journal of Nuclear Medicine|September 6, 2014
Preparation and evaluation of Lu-(177) phytate Complex for RadiosynovectomyHassan Yousefnia, Amir Reza Jalilian, Samaneh Zolghadri
Pageof 6